Sun Pharmaceutical Industries Limited (BOM:524715)
1,758.00
-2.00 (-0.11%)
At close: Oct 28, 2026
Sun Pharmaceutical Industries Employees
Sun Pharmaceutical Industries had 47,000 employees as of March 31, 2026. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
12.75M INR
Profits / Employee
2.57M INR
Market Cap
4.22T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,000 | 4,000 | 9.30% |
| Mar 31, 2025 | 43,000 | 0 | - |
| Mar 31, 2024 | 43,000 | 2,000 | 4.88% |
| Mar 31, 2023 | 41,000 | 3,000 | 7.89% |
| Mar 31, 2022 | 38,000 | 1,000 | 2.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 47,000 |
| Cipla | 31,369 |
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 29,209 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 19,346 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 16,946 |
Sun Pharmaceutical Industries News
- 5 days ago - Sun Pharma Reports Durable UNLOXCYT Responses In Advanced Skin Cancer - Nasdaq
- 8 days ago - Sun Pharma's UNLOXCYT Added As NCCN Category 2A Option For Locally Advanced Skin Cancer - Nasdaq
- 13 days ago - Indoco Remedies Share Price Quietly Does Something Most Mid-Cap Pharma Stocks Won’t - ABC Money
- 21 days ago - India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures - Reuters
- 27 days ago - Sun Pharma Reports Two-Year LEQSELVI Data In Severe Alopecia Areata - Nasdaq
- 4 weeks ago - Mayne Pharma, Sun Pharma Settle IMVEXXY Patent Case, Generic Entry Set For 2032 - Nasdaq
- 4 weeks ago - Mayne Pharma Settles IMVEXXY Patent Litigation With Sun Pharma - Nasdaq
- 4 weeks ago - India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say - Reuters